4.5 Article

Open chromatin profiling of human postmortem brain infers functional roles for non-coding schizophrenia loci

Journal

HUMAN MOLECULAR GENETICS
Volume 26, Issue 10, Pages 1942-1951

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/hmg/ddx103

Keywords

-

Funding

  1. National Institutes of Health [R01AG050986, R01MH109677]
  2. Brain Behavior Research Foundation [20540]
  3. Alzheimer's Association [NIRG-340998]
  4. Veterans Affairs [BX002395]
  5. Lundbeck Foundation [R155-2014-1724] Funding Source: researchfish

Ask authors/readers for more resources

Open chromatin provides access to DNA-binding proteins for the correct spatiotemporal regulation of gene expression. Mapping chromatin accessibility has been widely used to identify the location of cis regulatory elements (CREs) including promoters and enhancers. CREs show tissue- and cell-type specificity and disease-associated variants are often enriched for CREs in the tissues and cells that pertain to a given disease. To better understand the role of CREs in neuropsychiatric disorders we applied the Assay for Transposase Accessible Chromatin followed by sequencing (ATAC-seq) to neuronal and non-neuronal nuclei isolated fromfrozen postmortem human brain by fluorescence-activated nuclear sorting (FANS). Most of the identified open chromatin regions (OCRs) are differentially accessible between neurons and non-neurons, and show enrichment with known cell typemarkers, promoters and enhancers. Relative to those of non-neurons, neuronal OCRs aremore evolutionarily conserved and are enriched in distal regulatory elements. Transcription factor (TF) footprinting analysis identifies differences in the regulome between neuronal and non-neuronal cells and ascribes putative functional roles to a number of non-coding schizophrenia (SCZ) risk variants. Among the identified variants is a Single Nucleotide Polymorphism(SNP) proximal to the gene encoding SNX19. In vitro experiments reveal that this SNP leads to an increase in transcriptional activity. As elevated expression of SNX19 has been associated with SCZ, our data provide evidence that the identified SNP contributes to disease. These results represent the first analysis of OCRs and TF-binding sites in distinct populations of postmortemhuman brain cells and further our understanding of the regulome and the impact of neuropsychiatric disease-associated genetic risk variants.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available